Onconetix, Inc. Number of Reportable Segments
Onconetix, Inc. (ONCO) reported Number of Reportable Segments of 1 Segments for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-13
- Onconetix, Inc. number of reportable segments for the quarter ending 2026-03-31 was 1.00 Segment.
- Onconetix, Inc. number of reportable segments for fiscal 2025 was 1.00 Segment.
Segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 12 month |
|---|---|---|---|
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-13 | ||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-13 | ||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-14 |
pure
| Period end | Number of Reportable Segments 9 month |
|---|---|
| 2025-09-30 | 100.00% 10-Q · filed 2025-11-13 |
Segments
| Period end | Number of Reportable Segments 6 month |
|---|---|
| 2026-06-30 | 1.00 Segments 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |